Goldman Sachs: Maintains Buy rating on AK MEDICAL (01789) with a Target Price of 79 Hong Kong dollars.

Management expects that the Net income for 2025 will meet Institutions' market expectations (as of March 27, the expectation is 0.33-0.34 billion RMB), with net margin expected to stabilize around 20%. The gross margin is expected to improve due to the renewal of VBP contracts and increased profitability from overseas Business; however, expenses incurred from the commissioning of the new factory will partially offset this Bullish outlook.

Zhitong FinanceMar 30 22:21 ET

Does AK Medical Holdings (HKG:1789) Have A Healthy Balance Sheet?

Simply Wall StMar 27 20:05 ET

Earnings Tell The Story For AK Medical Holdings Limited (HKG:1789) As Its Stock Soars 29%

Simply Wall StMar 27 19:44 ET

AK Medical's 2024 Profit Rises 50%

MT NewswiresMar 27 05:50 ET

Express News | AK Medical - Final Dividend of HK$7.2 Cents per Share

ReutersMar 26 10:38 ET

Express News | AK Medical Holdings FY Revenue RMB 1,346.4 Million

ReutersMar 26 10:37 ET